Erectile Dysfunction Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Erectile dysfunction treatment market: By Product (Sildenafil [Viagra], Tadalafil [Adcirca, Cialis], Vardenafil [Staxyn, Levitra], Avanafil [Stendra], Others), By Distribution channel (Hospitals, Clinics, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Erectile Dysfunction Treatment Market size is valued at USD 3612.05 million in 2021 and is expected to reach USD 5951.36 million by 2028, at a CAGR of 7.1% during the forecast period 2022-2028. The inability to achieve or sustain a firm adequate penile erection during intercourse is referred to as erectile dysfunction. In guys, it is the most frequent sexual health disorder. Stress has an impact on the patient’s physical and psychological wellbeing. Physiological causes such as high blood pressure, high cholesterol, obesity, diabetes, smoking or tobacco use, and psychological ones such as stress, depression, mental health disorders, and so on cause erectile dysfunction. A key element driving the growth of the market for erectile dysfunction treatments is the increase in the number of individuals suffering from erectile dysfunction. Diabetes, renal disease, prostate cancer, high blood pressure, and physical injury to the prostate, penis, and pelvis can all contribute to the condition. Erectile dysfunction can also be caused by emotional and psychological difficulties like sadness, stress, and worry. Prescription pharmaceuticals such antidepressants, opioid pain relievers, chemotherapeutic agents, hormone therapies, amphetamines, and several sleeping prescriptions might also contribute to this disease.  this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Erectile Dysfunction Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Erectile Dysfunction Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Erectile Dysfunction Treatment Market

MARKET SUMMARY
-
7.1% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.1%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Erectile Dysfunction Treatment Market

  • The global Erectile Dysfunction Treatment Market report gives comprehensive outlook on Erectile Dysfunction Treatment Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Erectile Dysfunction Treatment Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Pfizer, Inc. (U.S)
  • Bayer AG (Germany)
  • Eli Lilly and Company (U.S)
  • (Brazil)
  • Apricus Biosciences Inc. (U.S)
Erectile Dysfunction Treatment Market

DRIVERS AND RESTRAINTS

The rise in the number of people suffering from erectile dysfunction is a primary factor driving the global erectile dysfunction therapy market. According to statistics, one out of every ten males in the world suffers from ED. Over 30 million men in the United States alone suffer from ED, and the figure is anticipated to climb in the coming years. Men between the ages of 20 and 29 had a 65 percent likelihood of having ED, compared to older men aged 75 and up, who have a 77.5 percent chance of having ED.


North-America got significant share

Erectile Dysfunction Treatment Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Erectile dysfunction market is expanding at 7.1% CAGR over 2022 to 2028 to reach market value of US$ XX Mn by 2021
  • Based on the type, predictive analytics market is expanding at highest CAGR over the forecast period.
  • Based on region type, North America is expected to account for major market share.
  • Hospitals are prime channel for surgical instruments systems distributed across the globe
  • Players focusing on expanding geographic presence to garner market opportunities in developing economies

Key

Features of the Report

Erectile Dysfunction Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Research Methodology
    • Secondary and Primary research
      • Secondary Sources
      • Primary Sources
    • Market Revenue Estimation Methodology
    • Key Assumptions
    • Acronyms
  2. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  3. Executive summary
  4. Global Erectile Dysfunction Market Dynamic Factors
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  5. Unique Features of the Report
    • Competition analysis
      • Dash board of top players
      • Financial Analysis
      • Product & Services
      • Key Developments
      • Major Strategies
      • SWOT Analysis
    • Technological advancements in Erectile Dysfunction Market
    • Recent investments in the industry
    • Regulatory landscape
      • US.
      • Europe
    • PESTLE analysis
    • Porter’s analysis
    • Pipeline analysis
  6. Global Erectile Dysfunction Market , By Product, 2013 – 2017 and Forecast, 2018 – 2024
    • Sildenafil [Viagra]
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Tadalafil [Adcirca, Cialis]
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Vardenafil [Staxyn, Levitra]
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Avanafil [Stendra]
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Erectile Dysfunction Market Forecast, By End-Use, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Erectile Dysfunction Market Forecast, By Region Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • North America Erectile Dysfunction Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
      • Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Sildenafil [Viagra]
        • Tadalafil [Adcirca, Cialis]
        • Vardenafil [Staxyn, Levitra]
        • Avanafil [Stendra]
        • Others
      • End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • Hospitals
        • Clinics
        • Others
      • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
        • US.
        • Canada
      • Europe Erectile Dysfunction Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
        • Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Sildenafil [Viagra]
          • Tadalafil [Adcirca, Cialis]
          • Vardenafil [Staxyn, Levitra]
          • Avanafil [Stendra]
          • Others
        • End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Hospitals
          • Clinics
          • Others
        • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
          • Germany
          • UK
          • France
          • Spain
          • Italy
          • Russia
          • Poland
          • Rest of Europe
        • Asia-Pacific Erectile Dysfunction Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
          • Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
            • Sildenafil [Viagra]
            • Tadalafil [Adcirca, Cialis]
            • Vardenafil [Staxyn, Levitra]
            • Avanafil [Stendra]
            • Others
          • End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
            • Hospitals
            • Clinics
            • Others
          • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Latin America Erectile Dysfunction Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Sildenafil [Viagra]
      • Tadalafil [Adcirca, Cialis]
      • Vardenafil [Staxyn, Levitra]
      • Avanafil [Stendra]
      • Others
    • End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospitals
      • Clinics
      • Others
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East & Africa (MEA) Erectile Dysfunction Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Sildenafil [Viagra]
      • Tadalafil [Adcirca, Cialis]
      • Vardenafil [Staxyn, Levitra]
      • Avanafil [Stendra]
      • Others
    • End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
      • Hospitals
      • Clinics
      • Others
    • Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and
  1. Y-o-Y Growth (%)
    • Gulf Cooperation Council (GCC) Countries
    • Israel
    • South Africa
    • Rest of MEA
  2. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Pfizer, Inc. (U.S)
      • Bayer AG (Germany)
      • Eli Lilly and Company (U.S)
      • (Brazil)
      • Apricus Biosciences Inc. (U.S)
      • Meda Pharmaceuticals, Inc. (U.S)
      • K. Chemicals Co. Ltd.(Korea)
      • Vivus, Inc. (U.S)
      • Dong-A ST (South Korea)

Report

Company Profile

  • Pfizer, Inc. (U.S)
  • Bayer AG (Germany)
  • Eli Lilly and Company (U.S)
  • (Brazil)
  • Apricus Biosciences Inc. (U.S)
  • Meda Pharmaceuticals, Inc. (U.S)
  • K. Chemicals Co. Ltd.(Korea)
  • Vivus, Inc. (U.S)
  • Dong-A ST (South Korea)

Description

Erectile Dysfunction Treatment Market size is valued at USD 3612.05 million in 2021 and is expected to reach USD 5951.36 million by 2028, at a CAGR of 7.1% during the forecast period 2022-2028. The inability to achieve or sustain a firm adequate penile erection during intercourse is referred to as erectile dysfunction. In guys, it is the most frequent sexual health disorder. Stress has an impact on the patient’s physical and psychological wellbeing. Physiological causes such as high blood pressure, high cholesterol, obesity, diabetes, smoking or tobacco use, and psychological ones such as stress, depression, mental health disorders, and so on cause erectile dysfunction. A key element driving the growth of the market for erectile dysfunction treatments is the increase in the number of individuals suffering from erectile dysfunction. Diabetes, renal disease, prostate cancer, high blood pressure, and physical injury to the prostate, penis, and pelvis can all contribute to the condition. Erectile dysfunction can also be caused by emotional and psychological difficulties like sadness, stress, and worry. Prescription pharmaceuticals such antidepressants, opioid pain relievers, chemotherapeutic agents, hormone therapies, amphetamines, and several sleeping prescriptions might also contribute to this disease.  this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Erectile Dysfunction Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Erectile Dysfunction Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX